$VXRT
Vaxart, Inc. Stock $vxrt

$vxrt Overview Financials Valuation SEC Filings Company Website

2019 Q4 Form 10-K Financial Statement

#000143774921004115 Filed on February 25, 2021

Income Statement

Concept	2019 Q4	2018 Q4	2018 Q3
Revenue	$3.916M	$1.767M	$281.0K
YoY Change	121.62%	-34.56%	181.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$1.330M	$1.230M	$1.670M
YoY Change	8.13%	-147.31%	-27.39%
% of Gross Profit
Research & Development	$3.290M	$4.470M	$4.381M
YoY Change	-26.4%	78.8%	56.46%
% of Gross Profit
Depreciation & Amortization	$750.0K	$820.0K	$130.0K
YoY Change	-8.54%	115.79%	30.0%
% of Gross Profit
Operating Expenses	$9.542M	$5.953M	$6.161M
YoY Change	60.29%	138.12%	120.04%
Operating Profit			-$5.880M
YoY Change			17.6%
Interest Expense	$30.00K	-$160.0K	$129.0K
YoY Change	-118.75%		29.0%
% of Operating Profit
Other Income/Expense, Net	-$510.0K	-$560.0K	-$668.0K
YoY Change	-8.93%	40.0%	122.67%
Pretax Income	-$6.210M	-$4.820M	-$6.548M
YoY Change	28.84%	46.06%	23.55%
Income Tax	$200.0K	$80.00K
% Of Pretax Income
Net Earnings	-$6.409M	-$4.902M	-$6.548M
YoY Change	30.74%	44.18%	23.55%
Net Earnings / Revenue	-163.66%	-277.42%	-2330.25%
Basic Earnings Per Share		-$0.69	-$0.92
Diluted Earnings Per Share	-$133.5K	-$0.69	-$0.92
COMMON SHARES
Basic Shares Outstanding	47.72M
Diluted Shares Outstanding

Balance Sheet

Concept	2019 Q4	2018 Q4	2018 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$13.50M	$11.50M	$17.90M
YoY Change	17.39%	283.33%	-47.51%
Cash & Equivalents	$13.53M	$11.51M	$17.92M
Short-Term Investments		$0.00	$0.00
Other Short-Term Assets	$500.0K	$1.300M	$1.000M
YoY Change	-61.54%	1200.0%	233.33%
Inventory
Prepaid Expenses
Receivables	$3.619M	$1.796M	$100.0K
Other Receivables	$0.00	$1.800M	$200.0K
Total Short-Term Assets	$17.60M	$14.65M	$19.20M
YoY Change	20.16%	-54.8%	-44.35%
LONG-TERM ASSETS
Property, Plant & Equipment	$210.0K	$1.066M	$1.100M
YoY Change	-80.3%	433.0%	450.0%
Goodwill
YoY Change
Intangibles	$17.09M	$19.41M
YoY Change	-11.95%
Long-Term Investments
YoY Change
Other Assets	$141.0K	$103.0K
YoY Change	36.89%
Total Long-Term Assets	$19.43M	$20.58M	$21.40M
YoY Change	-5.58%	10191.0%	10600.0%
TOTAL ASSETS
Total Short-Term Assets	$17.60M	$14.65M	$19.20M
Total Long-Term Assets	$19.43M	$20.58M	$21.40M
Total Assets	$37.03M	$35.23M	$40.60M
YoY Change	5.12%	8.06%	17.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$852.0K	$962.0K	$1.300M
YoY Change	-11.43%	-43.41%	0.0%
Accrued Expenses	$4.565M	$1.518M	$1.600M
YoY Change	200.72%	-39.28%	-27.27%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$100.0K
YoY Change
Long-Term Debt Due	$0.00	$1.700M	$1.700M
YoY Change	-100.0%	13.33%	750.0%
Total Short-Term Liabilities	$9.174M	$7.475M	$8.000M
YoY Change	22.73%	31.14%	53.85%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$1.900M	$2.300M
YoY Change	-100.0%	-95.09%	2200.0%
Other Long-Term Liabilities	$18.00K	$157.0K	$14.30M
YoY Change	-88.54%	57.0%	14200.0%
Total Long-Term Liabilities	$18.00K	$157.0K	$16.60M
YoY Change	-88.54%	57.0%	16500.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$9.174M	$7.475M	$8.000M
Total Long-Term Liabilities	$18.00K	$157.0K	$16.60M
Total Liabilities	$24.08M	$23.99M	$24.60M
YoY Change	0.38%	10.04%	18.27%
SHAREHOLDERS EQUITY
Retained Earnings	-$116.7M	-$97.99M
YoY Change	19.06%	-43.19%
Common Stock	$129.6M	$109.2M
YoY Change	18.66%	-33.52%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$12.95M	$11.21M	$15.99M
YoY Change
Total Liabilities & Shareholders Equity	$37.03M	$35.23M	$40.60M
YoY Change	5.12%	8.06%	17.0%

Cashflow Statement

Concept	2019 Q4	2018 Q4	2018 Q3
OPERATING ACTIVITIES
Net Income	-$6.409M	-$4.902M	-$6.548M
YoY Change	30.74%	44.18%	23.55%
Depreciation, Depletion And Amortization	$750.0K	$820.0K	$130.0K
YoY Change	-8.54%	115.79%	30.0%
Cash From Operating Activities	-$3.790M	-$5.700M	-$5.360M
YoY Change	-33.51%	2.89%	19.11%
INVESTING ACTIVITIES
Capital Expenditures	-$10.00K	-$200.0K	-$170.0K
YoY Change	-95.0%	66.67%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	$0.00
YoY Change		-100.0%	-100.0%
Cash From Investing Activities	-$10.00K	-$200.0K	-$170.0K
YoY Change	-95.0%	-93.79%	-102.66%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-2.230M	-520.0K	-470.0K
YoY Change	328.85%	-2700.0%
NET CHANGE
Cash From Operating Activities	-3.790M	-5.700M	-5.360M
Cash From Investing Activities	-10.00K	-200.0K	-170.0K
Cash From Financing Activities	-2.230M	-520.0K	-470.0K
Net Change In Cash	-6.030M	-6.420M	-6.000M
YoY Change	-6.07%	-26.54%	-415.79%
FREE CASH FLOW
Cash From Operating Activities	-$3.790M	-$5.700M	-$5.360M
Capital Expenditures	-$10.00K	-$200.0K	-$170.0K
Free Cash Flow	-$3.780M	-$5.500M	-$5.190M
YoY Change	-31.27%	1.48%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2020	dei	Amendment Flag AmendmentFlag	false
CY2020	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2020	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2020	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
CY2020	dei	Document Period End Date DocumentPeriodEndDate	2020-12-31
CY2020	dei	Document Type DocumentType	10-K
CY2020	dei	Entity Central Index Key EntityCentralIndexKey	0000072444
CY2021Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	117766672
CY2020	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2020	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2020	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2020	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2020Q2	dei	Entity Public Float EntityPublicFloat	842046746
CY2020	dei	Entity Registrant Name EntityRegistrantName	Vaxart, Inc.
CY2020	dei	Entity Shell Company EntityShellCompany	false
CY2020	dei	Entity Small Business EntitySmallBusiness	false
CY2020	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2018Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment	170000
CY2018Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Indefinite Lived Intangible Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets	1600000
CY2018Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill	22100000
CY2018Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet	38549000
CY2018	us-gaap	Business Combination Bargain Purchase Gain Recognized Amount BusinessCombinationBargainPurchaseGainRecognizedAmount	6760000
CY2020	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2019Q4	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	98000
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1732000
CY2019	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2320000
CY2018	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2727000
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	19183231
CY2019	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	19163520
CY2018	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1261124
CY2020Q4	us-gaap	Assets Assets	152582000
CY2019Q4	us-gaap	Assets Assets	37032000
CY2020Q4	us-gaap	Assets Current AssetsCurrent	128531000
CY2019Q4	us-gaap	Assets Current AssetsCurrent	17598000
CY2020	us-gaap	Business Combination Bargain Purchase Gain Recognized Amount BusinessCombinationBargainPurchaseGainRecognizedAmount
CY2019	us-gaap	Business Combination Bargain Purchase Gain Recognized Amount BusinessCombinationBargainPurchaseGainRecognizedAmount
CY2018Q1	us-gaap	Business Combination Consideration Transferred1 BusinessCombinationConsiderationTransferred1	31789000
CY2020	dei	Security12b Title Security12bTitle	Common stock, $0.0001 par value
CY2020	dei	Trading Symbol TradingSymbol	vxrt
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2133000
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	852000
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	334000
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3619000
CY2018	us-gaap	Accretion Expense AccretionExpense	2000
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4799000
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4565000
CY2020Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	777000
CY2019Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	2000
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	573000
CY2019Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	459000
CY2020Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	272274000
CY2019Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	129608000
CY2018	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	539000
CY2019	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	627000
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4358000
CY2019	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	560000
CY2018	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	70000
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0
CY2020	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium
CY2019	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium
CY2018	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	18000
CY2018	us-gaap	Business Combination Consideration Transferred1 BusinessCombinationConsiderationTransferred1	31789000
CY2018Q1	us-gaap	Business Combination Consideration Transferred Equity Interests Issued And Issuable BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable	31789000
CY2018Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets	64497000
CY2018Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents	25525000
CY2018Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Prepaid Expense And Other Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets	436000
CY2018Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Receivables BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables	14666000
CY2018Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Payable BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable	3304000
CY2018Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Other BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther	6744000
CY2020Q4	us-gaap	Cash Cash	66865000
CY2019Q4	us-gaap	Cash Cash	13511000
CY2020	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition
CY2019	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition
CY2018	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	25525000
CY2018	us-gaap	Business Exit Costs1 BusinessExitCosts1	359000
CY2020	us-gaap	Business Exit Costs1 BusinessExitCosts1
CY2019	us-gaap	Business Exit Costs1 BusinessExitCosts1
CY2020	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	5664000
CY2019	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1929000
CY2018	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	126870000
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13526000
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11506000
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1571000
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	113344000
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2020000
CY2018	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	9935000
CY2020Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1244974
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2020Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	9288870
CY2019Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	45476994
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2020Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.10
CY2020Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000
CY2020Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2020Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	110271093
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	48254994
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	110271093
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	48254994
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	11000
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	5000
CY2020	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;">Concentration of Credit Risk</div> – Financial instruments that potentially subject the Company to significant concentrations of credit risk consist principally of cash, cash equivalents, short-term investments and accounts receivable. The Company places its cash, cash equivalents and short-term investments at financial institutions that management believes are of high credit quality. The Company is exposed to credit risk in the event of default by the financial institutions holding the cash and cash equivalents to the extent such amounts are in excess of the federally insured limits. The Company has <div style="display: inline; font-style: italic; font: inherit;">not</div> experienced any losses on its deposits since inception.</div> <div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The primary focus of the Company's investment strategy is to preserve capital and meet liquidity requirements. The Company's investment policy addresses the level of credit exposure by limiting the concentration in any <div style="display: inline; font-style: italic; font: inherit;">one</div> corporate issuer or sector and establishing a minimum allowable credit rating. The Company generally requires <div style="display: inline; font-style: italic; font: inherit;">no</div> collateral from its customers.</div></div></div>
CY2020Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	0
CY2019Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	181000
CY2020Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	0
CY2019Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	0
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit
CY2019	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit
CY2018	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit
CY2020	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	235000
CY2019	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	488000
CY2018	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	106000
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	238000
CY2019	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	490000
CY2018	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	109000
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	3000
CY2019	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	2000
CY2018	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	3000
CY2020	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1
CY2019	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1
CY2018	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	35577000
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit
CY2019	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit
CY2018	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit
CY2020	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit
CY2019	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit
CY2018	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit
CY2018	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit
CY2020Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	9440000
CY2019Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	9154000
CY2018Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	9976000
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit
CY2019	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit
CY2018	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	31392000
CY2019Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	22519000
CY2018Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	58602000
CY2020Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	9440000
CY2019Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	9154000
CY2018Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	9976000
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	14161000
CY2019Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	6924000
CY2018Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	43822000
CY2020Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1327000
CY2019Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1253000
CY2018Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	714000
CY2020Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	2497000
CY2019Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	1591000
CY2018Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	3357000
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	21952000
CY2019Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	13365000
CY2018Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	48626000
CY2020Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities
CY2019Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities
CY2018Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities
CY2020Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	1608000
CY2019Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	424000
CY2018Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements
CY2020Q4	us-gaap	Deferred Tax Liabilities Other Finite Lived Assets DeferredTaxLiabilitiesOtherFiniteLivedAssets	7832000
CY2019Q4	us-gaap	Deferred Tax Liabilities Other Finite Lived Assets DeferredTaxLiabilitiesOtherFiniteLivedAssets	8730000
CY2018Q4	us-gaap	Deferred Tax Liabilities Other Finite Lived Assets DeferredTaxLiabilitiesOtherFiniteLivedAssets	9976000
CY2020	us-gaap	Defined Contribution Plan Administrative Expenses DefinedContributionPlanAdministrativeExpenses	10000
CY2019	us-gaap	Defined Contribution Plan Administrative Expenses DefinedContributionPlanAdministrativeExpenses	14000
CY2018	us-gaap	Defined Contribution Plan Administrative Expenses DefinedContributionPlanAdministrativeExpenses	9000
CY2020	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	96000
CY2019	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	140000
CY2018	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	124000
CY2020	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent DefinedContributionPlanEmployerMatchingContributionPercent	0.03
CY2020	us-gaap	Depreciation Depreciation	114000
CY2019	us-gaap	Depreciation Depreciation	504000
CY2018	us-gaap	Depreciation Depreciation	476000
CY2020	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2710000
CY2019	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3596000
CY2018	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3203000
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	9174000
CY2020	us-gaap	Longterm Purchase Commitment Period LongtermPurchaseCommitmentPeriod	P1Y180D
CY2020	us-gaap	Dilutive Securities DilutiveSecurities	0
CY2019	us-gaap	Dilutive Securities DilutiveSecurities	0
CY2018	us-gaap	Dilutive Securities DilutiveSecurities	0
CY2020	us-gaap	Dividends Common Stock DividendsCommonStock	0
CY2018Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.54
CY2018Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.24
CY2018Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.92
CY2018Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.69
CY2020	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.36
CY2019	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.86
CY2018	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-2.90
CY2020Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.02
CY2020Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.12
CY2020Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.08
CY2020Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.13
CY2019Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.18
CY2019Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.39
CY2019Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.32
CY2019Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.13
CY2018Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.49
CY2018Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.24
CY2018Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.92
CY2018Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.69
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.007
CY2019	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.027
CY2018	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.006
CY2019	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2018	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.268
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	1.942
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes	-0.025
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes	-0.009
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
CY2020	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.029
CY2019	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.004
CY2018	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.006
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.204
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.007
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.026
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.031
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.022
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	-0.037
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	-0.025
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.001
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.045
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0.028
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0.017
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0.021
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Tax Settlements EffectiveIncomeTaxRateReconciliationTaxSettlements	0.005
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Tax Settlements EffectiveIncomeTaxRateReconciliationTaxSettlements	-2.083
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Tax Settlements EffectiveIncomeTaxRateReconciliationTaxSettlements
CY2020Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1618000
CY2019Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	903000
CY2018	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	3000
CY2018	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
CY2018	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases Sales Issuances Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements
CY2018	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	70000
CY2017Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	67000
CY2018Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	5019000
CY2019Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	5087000
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	6703000
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	1732000
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	1731000
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	1732000
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	1732000
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	1731000
CY2020Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	20380000
CY2019Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	22180000
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	15361000
CY2020	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-13000
CY2019	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-32000
CY2018	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-266000
CY2020	us-gaap	Gain Loss On Investments GainLossOnInvestments
CY2019	us-gaap	Gain Loss On Investments GainLossOnInvestments
CY2018	us-gaap	Gain Loss On Investments GainLossOnInvestments	-3000
CY2020	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment
CY2019	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	1000
CY2018	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-11000
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt
CY2019	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-100000
CY2018	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	15202000
CY2019	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6187000
CY2018	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6681000
CY2020	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
CY2019	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
CY2018	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	1600000
CY2018	us-gaap	Impairment Of Leasehold ImpairmentOfLeasehold	106000
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-31982000
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-18155000
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-17898000
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	238000
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	490000
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	109000
CY2020	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1207000
CY2019	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-62000
CY2018	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-3784000
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-3285000
CY2019	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1823000
CY2018	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-13500000
CY2020	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-579000
CY2019	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	2312000
CY2018	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-6393000
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1108000
CY2019	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-855000
CY2018	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	873000
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	15361000
CY2019Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	17093000
CY2020	us-gaap	Interest Expense InterestExpense
CY2019	us-gaap	Interest Expense InterestExpense	315000
CY2018	us-gaap	Interest Expense InterestExpense	821000
CY2020	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	75000
CY2019	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	149000
CY2018	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	58000
CY2020	us-gaap	Interest Paid Net InterestPaidNet
CY2019	us-gaap	Interest Paid Net InterestPaidNet	227000
CY2018	us-gaap	Interest Paid Net InterestPaidNet	356000
CY2020	us-gaap	Lease Cost LeaseCost	1205000
CY2019	us-gaap	Lease Cost LeaseCost	919000
CY2019Q4	us-gaap	Legal Fees LegalFees	2000
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	8772000
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	2633000
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	1112000
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1641000
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1585000
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1801000
CY2020Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1564000
CY2020Q4	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P5Y
CY2020Q4	us-gaap	Liabilities Liabilities	29178000
CY2019Q4	us-gaap	Liabilities Liabilities	24080000
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	152582000
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	37032000
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	11763000
CY2020Q4	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	60005000
CY2019Q4	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	15000
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	138314000
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	15960000
CY2018	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1729000
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1220000
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-850000
CY2018	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	26212000
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-23750000
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-13090000
CY2018	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-14548000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-32220000
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-18645000
CY2018	us-gaap	Net Income Loss NetIncomeLoss	-18007000
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-1297000
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-8977000
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-8085000
CY2020Q4	us-gaap	Net Income Loss NetIncomeLoss	-13861000
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	-1339000
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	-5637000
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	-5260000
CY2019Q4	us-gaap	Net Income Loss NetIncomeLoss	-6409000
CY2018Q1	us-gaap	Net Income Loss NetIncomeLoss	2314000
CY2018Q2	us-gaap	Net Income Loss NetIncomeLoss	-8871000
CY2018Q3	us-gaap	Net Income Loss NetIncomeLoss	-6548000
CY2018Q4	us-gaap	Net Income Loss NetIncomeLoss	-4902000
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-32220000
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-18645000
CY2018	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-18346000
CY2018Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	1975000
CY2018Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-8871000
CY2018Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-6548000
CY2018Q4	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-4902000
CY2020	us-gaap	Noncash Or Part Noncash Acquisition Value Of Assets Acquired1 NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1	78000
CY2019	us-gaap	Noncash Or Part Noncash Acquisition Value Of Assets Acquired1 NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1	4000
CY2018	us-gaap	Noncash Or Part Noncash Acquisition Value Of Assets Acquired1 NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1	52000
CY2020	us-gaap	Operating Expenses OperatingExpenses	34216000
CY2019	us-gaap	Operating Expenses OperatingExpenses	25647000
CY2018	us-gaap	Operating Expenses OperatingExpenses	25915000
CY2020Q1	us-gaap	Operating Expenses OperatingExpenses	3596000
CY2020Q2	us-gaap	Operating Expenses OperatingExpenses	9049000
CY2020Q3	us-gaap	Operating Expenses OperatingExpenses	7854000
CY2020Q4	us-gaap	Operating Expenses OperatingExpenses	13717000
CY2019Q1	us-gaap	Operating Expenses OperatingExpenses	5855000
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1472000
CY2020	us-gaap	Operating Lease Payments OperatingLeasePayments	1111000
CY2019	us-gaap	Operating Lease Payments OperatingLeasePayments	983000
CY2018	us-gaap	Operating Lease Payments OperatingLeasePayments	875000
CY2019Q2	us-gaap	Operating Expenses OperatingExpenses	5082000
CY2019Q3	us-gaap	Operating Expenses OperatingExpenses	5168000
CY2019Q4	us-gaap	Operating Expenses OperatingExpenses	9542000
CY2018Q1	us-gaap	Operating Expenses OperatingExpenses	5418000
CY2018Q2	us-gaap	Operating Expenses OperatingExpenses	8383000
CY2018Q3	us-gaap	Operating Expenses OperatingExpenses	6161000
CY2018Q4	us-gaap	Operating Expenses OperatingExpenses	5953000
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-30170000
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	-15785000
CY2018	us-gaap	Operating Income Loss OperatingIncomeLoss	-21756000
CY2020	us-gaap	Operating Lease Cost OperatingLeaseCost	1145000
CY2019	us-gaap	Operating Lease Cost OperatingLeaseCost	959000
CY2018Q4	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	253000
CY2020Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	7208000
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2052000
CY2019Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	841000
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	5156000
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	6838000
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1990000
CY2020Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0994
CY2020Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y25D
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	632000
CY2019Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	254000
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	372000
CY2019Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	141000
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	109000
CY2019Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	18000
CY2020	us-gaap	Other Noncash Expense OtherNoncashExpense
CY2019	us-gaap	Other Noncash Expense OtherNoncashExpense	88000
CY2018	us-gaap	Other Noncash Expense OtherNoncashExpense	448000
CY2018Q1	us-gaap	Other Ownership Interests Value OtherOwnershipInterestsValue	21400000
CY2018	us-gaap	Payments For Restructuring PaymentsForRestructuring	41000
CY2019	us-gaap	Payments For Restructuring PaymentsForRestructuring	1272000
CY2020	us-gaap	Payments For Restructuring PaymentsForRestructuring	2799000
CY2019Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	320000
CY2020	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross
CY2019	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross
CY2018	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	21000
CY2020	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments
CY2019	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments
CY2018	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	573000
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1223000
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	850000
CY2018	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	707000
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-116661000
CY2020	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	4046000
CY2019	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	9862000
CY2020	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact
CY2019	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact
CY2018	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	339000
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2019Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2019Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2019Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2019Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2019Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1327000
CY2019Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	453000
CY2020	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;">Reclassification</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Prior year data is subject to reclassification to conform to current year presentation.</div></div></div>
CY2019Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	2500000
CY2020	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
CY2019	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
CY2018	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments	1988000
CY2020	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	3000
CY2019	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment
CY2018	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment
CY2020	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	602000
CY2019	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised
CY2018	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	13000
CY2020	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	25951000
CY2019	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	180000
CY2018	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2053000
CY2019Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	669000
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1480000
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	210000
CY2020Q4	us-gaap	Restructuring Reserve RestructuringReserve
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-148881000
CY2020Q4	us-gaap	Purchase Obligation PurchaseObligation	24600000
CY2020	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt
CY2019	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	3799000
CY2018	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	1528000
CY2020	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable
CY2019	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable
CY2018	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	214000
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	19863000
CY2019	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	14540000
CY2018	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	17275000
CY2020Q4	us-gaap	Restructuring And Related Cost Cost Incurred To Date1 RestructuringAndRelatedCostCostIncurredToDate1	4071000
CY2019	us-gaap	Restructuring Charges RestructuringCharges	4920000
CY2020	us-gaap	Restructuring Charges RestructuringCharges	122000
CY2018Q4	us-gaap	Restructuring Reserve RestructuringReserve
CY2019Q4	us-gaap	Restructuring Reserve RestructuringReserve	3648000
CY2018	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	4159000
CY2020Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	2902000
CY2020Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	523000
CY2020Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	265000
CY2020Q4	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	356000
CY2019Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	5407000
CY2019Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	85000
CY2019Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	454000
CY2019Q4	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	3916000
CY2018Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	1503000
CY2018Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	608000
CY2018Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	281000
CY2018Q4	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	1767000
CY2020Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	13000
CY2019Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	211000
CY2020Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P90D
CY2020Q4	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	1
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	4358000
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	627000
CY2018	us-gaap	Share Based Compensation ShareBasedCompensation	539000
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized	1600000
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.67
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	2.66
CY2018	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Other Share Increase Decrease In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsOtherShareIncreaseDecreaseInPeriodWeightedAverageExercisePrice	26.33
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized	6400000
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	200650
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	295180
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	1230863
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2886541
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.65
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	2200000
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	0
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	405977
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	252013
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	57751
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	89903
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	592528
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	105992
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	2610000
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	431100
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1791030
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	5579800
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Other Increases Decreases In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod	627106
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	22500000
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	6813033
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	304850
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	865163
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1811652
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.70
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	9.50
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	8.13
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.74
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	21600000
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	6502213
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	2.68
CY2018	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	6.49
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.45
CY2018	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	34.64
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	9.25
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	10.57
CY2018	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	5.90
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	1.57
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	1.65
CY2020Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.70
CY2018	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	5.17
CY2020Q4	us-gaap	Share Price SharePrice	5.71
CY2020Q1	us-gaap	Share Price SharePrice	1.70
CY2020Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	9900000
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P8Y237D
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y361D
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P8Y354D
CY2020Q4	us-gaap	Short Term Lease Commitment Amount ShortTermLeaseCommitmentAmount	0
CY2020	us-gaap	Short Term Lease Cost ShortTermLeaseCost	13000
CY2019	us-gaap	Short Term Lease Cost ShortTermLeaseCost	15000
CY2020	us-gaap	Stock Issued1 StockIssued1
CY2019	us-gaap	Stock Issued1 StockIssued1
CY2018	us-gaap	Stock Issued1 StockIssued1	31768000
CY2019Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	1200000
CY2018Q1	us-gaap	Stock Issued During Period Shares Reverse Stock Splits StockIssuedDuringPeriodSharesReverseStockSplits	7100000
CY2019	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0
CY2018	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	2013
CY2020	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	414676
CY2018	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	31768000
CY2018	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	35577000
CY2019	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	2440000
CY2018	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	13000
CY2020	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	602000
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	123404000
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	12952000
CY2020Q4	vxrt	Accrued Clinical And Manufacturing Expenses Current AccruedClinicalAndManufacturingExpensesCurrent	1772000
CY2019Q4	vxrt	Accrued Clinical And Manufacturing Expenses Current AccruedClinicalAndManufacturingExpensesCurrent	3228000
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	-38722000
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	11238000
CY2020	us-gaap	Sublease Income SubleaseIncome	217000
CY2019	us-gaap	Sublease Income SubleaseIncome	217000
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1281000
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	851000
CY2018Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1582000
CY2017Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1404000
CY2020	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	1000
CY2019	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	890000
CY2018	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	3000
CY2020	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0
CY2019	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0
CY2018	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	431000
CY2019	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	159000
CY2018	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	181000
CY2020	us-gaap	Use Of Estimates UseOfEstimates	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;">Use of Estimates</div> – The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses and disclosure of contingent assets and liabilities in the financial statements and accompanying notes. Actual results and outcomes could differ from these estimates and assumptions.</div></div></div>
CY2020	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	8600000
CY2019	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-35300000
CY2018	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	25700000
CY2020	us-gaap	Variable Lease Cost VariableLeaseCost	264000
CY2019	us-gaap	Variable Lease Cost VariableLeaseCost	162000
CY2020	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	88295762
CY2019	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	21569523
CY2018	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	6316065
CY2017Q4	vxrt	Accrued Lease Exit Costs AccruedLeaseExitCosts
CY2018Q4	vxrt	Accrued Lease Exit Costs AccruedLeaseExitCosts	233000
CY2020	vxrt	Adjustments To Additional Paid In Capital Disgorgement Of Shortswing Profits Net Of Costs AdjustmentsToAdditionalPaidInCapitalDisgorgementOfShortswingProfitsNetOfCosts	652000
CY2019Q1	vxrt	Gross Proceeds From Issuance Of Common Stock GrossProceedsFromIssuanceOfCommonStock	3000000
	vxrt	Impairment Of Property And Equipment ImpairmentOfPropertyAndEquipment	106000
CY2020	vxrt	Impairment Of Property And Equipment ImpairmentOfPropertyAndEquipment
CY2018	vxrt	Impairment Of Property And Equipment ImpairmentOfPropertyAndEquipment	106000
CY2020	vxrt	Business Combination Bargain Purchase Gain Loss Recognized Amount BusinessCombinationBargainPurchaseGainLossRecognizedAmount
CY2019	vxrt	Business Combination Bargain Purchase Gain Loss Recognized Amount BusinessCombinationBargainPurchaseGainLossRecognizedAmount
CY2018	vxrt	Business Combination Bargain Purchase Gain Loss Recognized Amount BusinessCombinationBargainPurchaseGainLossRecognizedAmount	6760000
CY2018Q4	vxrt	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Noncurrent Liability Related To Sale Of Future Royalties BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilityRelatedToSaleOfFutureRoyalties	15900000
CY2018Q1	vxrt	Business Combination Stock Conversion Shares Issued Per Common Share Of Surviving Entity BusinessCombinationStockConversionSharesIssuedPerCommonShareOfSurvivingEntity	0.22148
CY2020Q4	vxrt	Common Stock Number Of Votes Per Share CommonStockNumberOfVotesPerShare	1
CY2020Q4	vxrt	Contract With Customer Asset Revenue Recognized ContractWithCustomerAssetRevenueRecognized	219000
CY2019Q4	vxrt	Contract With Customer Asset Revenue Recognized ContractWithCustomerAssetRevenueRecognized	21000
CY2018	vxrt	Deferred Rent On Cease Use Date DeferredRentOnCeaseUseDate	19000
CY2020Q4	vxrt	Deferred Tax Assets Capitalized Research And Development DeferredTaxAssetsCapitalizedResearchAndDevelopment	4534000
CY2019Q4	vxrt	Deferred Tax Assets Capitalized Research And Development DeferredTaxAssetsCapitalizedResearchAndDevelopment	4773000
CY2018Q4	vxrt	Deferred Tax Assets Capitalized Research And Development DeferredTaxAssetsCapitalizedResearchAndDevelopment	2326000
CY2020Q4	vxrt	Deferred Tax Assets Lease Liabilities DeferredTaxAssetsLeaseLiabilities	1695000
CY2019Q4	vxrt	Deferred Tax Assets Lease Liabilities DeferredTaxAssetsLeaseLiabilities	492000
CY2018Q4	vxrt	Deferred Tax Assets Lease Liabilities DeferredTaxAssetsLeaseLiabilities
CY2020Q4	vxrt	Deferred Tax Assets Sale Of Future Royalty Rights DeferredTaxAssetsSaleOfFutureRoyaltyRights	7178000
CY2019Q4	vxrt	Deferred Tax Assets Sale Of Future Royalty Rights DeferredTaxAssetsSaleOfFutureRoyaltyRights	7486000
CY2018Q4	vxrt	Deferred Tax Assets Sale Of Future Royalty Rights DeferredTaxAssetsSaleOfFutureRoyaltyRights	8383000
CY2020	vxrt	Effective Income Tax Rate Reconciliation Bargain Purchase Gain Percent EffectiveIncomeTaxRateReconciliationBargainPurchaseGainPercent
CY2019	vxrt	Effective Income Tax Rate Reconciliation Bargain Purchase Gain Percent EffectiveIncomeTaxRateReconciliationBargainPurchaseGainPercent
CY2018	vxrt	Effective Income Tax Rate Reconciliation Bargain Purchase Gain Percent EffectiveIncomeTaxRateReconciliationBargainPurchaseGainPercent	0.081
CY2020	vxrt	Effective Income Tax Rate Reconciliation Global Intangible Lowtaxed Income Percent EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowtaxedIncomePercent
CY2019	vxrt	Effective Income Tax Rate Reconciliation Global Intangible Lowtaxed Income Percent EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowtaxedIncomePercent
CY2018	vxrt	Effective Income Tax Rate Reconciliation Global Intangible Lowtaxed Income Percent EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowtaxedIncomePercent	-0.088
CY2020	vxrt	Effective Income Tax Rate Reconciliation Nol And Credit Adjustments Percent EffectiveIncomeTaxRateReconciliationNOLAndCreditAdjustmentsPercent
CY2019	vxrt	Effective Income Tax Rate Reconciliation Nol And Credit Adjustments Percent EffectiveIncomeTaxRateReconciliationNOLAndCreditAdjustmentsPercent
CY2018	vxrt	Effective Income Tax Rate Reconciliation Nol And Credit Adjustments Percent EffectiveIncomeTaxRateReconciliationNOLAndCreditAdjustmentsPercent	-0.038
CY2018Q1	vxrt	Exchange Ratio Number Of Shares Exchanged Per Share ExchangeRatioNumberOfSharesExchangedPerShare	0.0201346
CY2019	vxrt	Impairment Of Property And Equipment ImpairmentOfPropertyAndEquipment	1272000
CY2018	vxrt	Reclassification Of Convertible Preferred Stock Warrant Liability To Equity ReclassificationOfConvertiblePreferredStockWarrantLiabilityToEquity	70000
CY2020Q4	vxrt	Reserve For Return Of Royalties Current ReserveForReturnOfRoyaltiesCurrent
CY2020	vxrt	Issuance Of Warrants To Placement Agents Designees IssuanceOfWarrantsToPlacementAgentsDesignees	453000
CY2019	vxrt	Issuance Of Warrants To Placement Agents Designees IssuanceOfWarrantsToPlacementAgentsDesignees	100000
CY2018	vxrt	Issuance Of Warrants To Placement Agents Designees IssuanceOfWarrantsToPlacementAgentsDesignees
CY2020	vxrt	Issuance Of Warrants To Underwriters Designees IssuanceOfWarrantsToUnderwritersDesignees
CY2019	vxrt	Issuance Of Warrants To Underwriters Designees IssuanceOfWarrantsToUnderwritersDesignees	830000
CY2018	vxrt	Issuance Of Warrants To Underwriters Designees IssuanceOfWarrantsToUnderwritersDesignees
CY2020Q4	vxrt	Lessee Finance Lease Number Of Leases LesseeFinanceLeaseNumberOfLeases	0
CY2020Q4	vxrt	Lessee Operating Lease Number Leases Exceeding One Year LesseeOperatingLeaseNumberLeasesExceedingOneYear	3
CY2020Q4	vxrt	Lessee Operating Lease Number Of Leases LesseeOperatingLeaseNumberOfLeases	6
CY2020Q4	vxrt	Lessee Operating Lease Number Of Rightofuse Leases Subleased LesseeOperatingLeaseNumberOfRightofuseLeasesSubleased	1
CY2020Q4	vxrt	Liability Related To Sale Of Future Royalties Current LiabilityRelatedToSaleOfFutureRoyaltiesCurrent	2779000
CY2019Q4	vxrt	Liability Related To Sale Of Future Royalties Current LiabilityRelatedToSaleOfFutureRoyaltiesCurrent	2916000
CY2020Q4	vxrt	Liability Related To Sale Of Future Royalties Noncurrent LiabilityRelatedToSaleOfFutureRoyaltiesNoncurrent	12150000
CY2019Q4	vxrt	Liability Related To Sale Of Future Royalties Noncurrent LiabilityRelatedToSaleOfFutureRoyaltiesNoncurrent	13416000
CY2020	vxrt	Noncash Interest Expense On Liability NoncashInterestExpenseOnLiability	1874000
CY2019	vxrt	Noncash Interest Expense On Liability NoncashInterestExpenseOnLiability	2073000
CY2018	vxrt	Noncash Interest Expense On Liability NoncashInterestExpenseOnLiability	1859000
CY2020	vxrt	Noncash Revenue Related To Sale Of Future Royalties NoncashRevenueRelatedToSaleOfFutureRoyalties	3277000
CY2019	vxrt	Noncash Revenue Related To Sale Of Future Royalties NoncashRevenueRelatedToSaleOfFutureRoyalties	3482000
CY2018	vxrt	Noncash Revenue Related To Sale Of Future Royalties NoncashRevenueRelatedToSaleOfFutureRoyalties	18000
CY2019Q4	vxrt	Operating Loss Carryforwards Annual Limitations OperatingLossCarryforwardsAnnualLimitations	62000
CY2020Q4	vxrt	Operating Loss Carryforwards Annual Limitations OperatingLossCarryforwardsAnnualLimitations	3200000
CY2019Q2	vxrt	Payments For Aggregate Commissions To Underwriters PaymentsForAggregateCommissionsToUnderwriters	750000
CY2020	vxrt	Proceeds Due For Sale Of Property And Equipment ProceedsDueForSaleOfPropertyAndEquipment
CY2019	vxrt	Proceeds Due For Sale Of Property And Equipment ProceedsDueForSaleOfPropertyAndEquipment	3000
CY2018	vxrt	Proceeds Due For Sale Of Property And Equipment ProceedsDueForSaleOfPropertyAndEquipment
CY2020	vxrt	Proceeds From Disgorgement Of Shortswing Profits Net Of Costs ProceedsFromDisgorgementOfShortswingProfitsNetOfCosts	652000
CY2019	vxrt	Proceeds From Disgorgement Of Shortswing Profits Net Of Costs ProceedsFromDisgorgementOfShortswingProfitsNetOfCosts
CY2018	vxrt	Proceeds From Disgorgement Of Shortswing Profits Net Of Costs ProceedsFromDisgorgementOfShortswingProfitsNetOfCosts
CY2020	vxrt	Proceeds From Exercise Of Prefunded Warrants ProceedsFromExerciseOfPrefundedWarrants
CY2019	vxrt	Proceeds From Exercise Of Prefunded Warrants ProceedsFromExerciseOfPrefundedWarrants	1226000
CY2018	vxrt	Proceeds From Exercise Of Prefunded Warrants ProceedsFromExerciseOfPrefundedWarrants
CY2020	vxrt	Property And Equipment Acquired As Incentive To Enter Operating Lease PropertyAndEquipmentAcquiredAsIncentiveToEnterOperatingLease	87000
CY2019	vxrt	Property And Equipment Acquired As Incentive To Enter Operating Lease PropertyAndEquipmentAcquiredAsIncentiveToEnterOperatingLease
CY2018	vxrt	Property And Equipment Acquired As Incentive To Enter Operating Lease PropertyAndEquipmentAcquiredAsIncentiveToEnterOperatingLease
CY2020	vxrt	Reclassification Of Convertible Preferred Stock Warrant Liability To Equity ReclassificationOfConvertiblePreferredStockWarrantLiabilityToEquity
CY2019	vxrt	Reclassification Of Convertible Preferred Stock Warrant Liability To Equity ReclassificationOfConvertiblePreferredStockWarrantLiabilityToEquity
CY2019Q4	vxrt	Reserve For Return Of Royalties Current ReserveForReturnOfRoyaltiesCurrent	178000
CY2020	vxrt	Restructuring Charges Reversals RestructuringChargesReversals	-849000
CY2019	vxrt	Restructuring Charges Reversals RestructuringChargesReversals	4920000
CY2018	vxrt	Restructuring Charges Reversals RestructuringChargesReversals
CY2020	vxrt	Restructuring Reversals Of Expenses RestructuringReversalsOfExpenses	971000
CY2020	vxrt	Share Based Compensation Arrangement By Share Based Payment Award Shares Available For Grant Decrease From Grants ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantDecreaseFromGrants	5579800
CY2018	vxrt	Stock Issued During Period Value Conversion Of Preferred Stock StockIssuedDuringPeriodValueConversionOfPreferredStock
CY2019	vxrt	Stock Issued During Period Value Exercise Of Common Stock Warrants StockIssuedDuringPeriodValueExerciseOfCommonStockWarrants	180000
CY2018	vxrt	Share Based Compensation Arrangement By Share Based Payment Award Canceled ShareBasedCompensationArrangementByShareBasedPaymentAwardCanceled	269148
CY2019	vxrt	Share Based Compensation Arrangement By Share Based Payment Award Canceled ShareBasedCompensationArrangementByShareBasedPaymentAwardCanceled	25100
CY2020	vxrt	Share Based Compensation Arrangement By Share Based Payment Award Canceled ShareBasedCompensationArrangementByShareBasedPaymentAwardCanceled	9573
CY2018	vxrt	Share Based Compensation Arrangement By Share Based Payment Award Forfeited ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeited	71500
CY2019	vxrt	Share Based Compensation Arrangement By Share Based Payment Award Forfeited ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeited	483849
CY2020	vxrt	Share Based Compensation Arrangement By Share Based Payment Award Forfeited ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeited	105910
CY2018	vxrt	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant Consummation Of Merger ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantConsummationOfMerger	291102
CY2019	vxrt	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Removed From Plan ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesRemovedFromPlan	223389
CY2018	vxrt	Share Based Compensation Arrangement By Share Based Payment Award Shares Available For Grant Decrease From Grants ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantDecreaseFromGrants	431100
CY2019	vxrt	Share Based Compensation Arrangement By Share Based Payment Award Shares Available For Grant Decrease From Grants ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantDecreaseFromGrants	1791030
CY2020	vxrt	Stock Issued During Period Value Exercise Of Common Stock Warrants StockIssuedDuringPeriodValueExerciseOfCommonStockWarrants	25951000
CY2019	vxrt	Stock Issued During Period Value Exercise Of Pre Funded Warrants StockIssuedDuringPeriodValueExerciseOfPreFundedWarrants	1226000

Files In Submission

Name	View Source	Status
0001437749-21-004115-index-headers.html	Edgar Link	pending
0001437749-21-004115-index.html	Edgar Link	pending
0001437749-21-004115.txt	Edgar Link	pending
0001437749-21-004115-xbrl.zip	Edgar Link	pending
ex_217178.htm	Edgar Link	pending
ex_217179.htm	Edgar Link	pending
ex_217180.htm	Edgar Link	pending
ex_217181.htm	Edgar Link	pending
ex_217182.htm	Edgar Link	pending
ex_224964.htm	Edgar Link	pending
ex_227470.htm	Edgar Link	pending
fig14a.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
j10.jpg	Edgar Link	pending
j11.jpg	Edgar Link	pending
j12.jpg	Edgar Link	pending
j13.jpg	Edgar Link	pending
j14.jpg	Edgar Link	pending
j15.jpg	Edgar Link	pending
j16.jpg	Edgar Link	pending
j17.jpg	Edgar Link	pending
j18i.jpg	Edgar Link	pending
j18ii.jpg	Edgar Link	pending
j19i.jpg	Edgar Link	pending
j19ii.jpg	Edgar Link	pending
j2.jpg	Edgar Link	pending
j20.jpg	Edgar Link	pending
j3.jpg	Edgar Link	pending
j4.jpg	Edgar Link	pending
j5.jpg	Edgar Link	pending
j6.jpg	Edgar Link	pending
j7.jpg	Edgar Link	pending
j8.jpg	Edgar Link	pending
j9.jpg	Edgar Link	pending
perfchart.jpg	Edgar Link	pending
pictab1.jpg	Edgar Link	pending
pipelineye.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
tabn1.jpg	Edgar Link	pending
tabn2.jpg	Edgar Link	pending
tabn3.jpg	Edgar Link	pending
tabn4.jpg	Edgar Link	pending
tabn5.jpg	Edgar Link	pending
vxrt-20201231.xml	Edgar Link	completed
vxrt-20201231.xsd	Edgar Link	pending
vxrt-20201231_cal.xml	Edgar Link	unprocessable
vxrt-20201231_def.xml	Edgar Link	unprocessable
vxrt-20201231_lab.xml	Edgar Link	unprocessable
vxrt-20201231_pre.xml	Edgar Link	unprocessable
vxrt20201211_10k.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$VXRT
Vaxart, Inc. Stock $vxrt

2019 Q4 Form 10-K Financial Statement

#000143774921004115 Filed on February 25, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VXRT Vaxart, Inc. Stock $vxrt

2019 Q4 Form 10-K Financial Statement

#000143774921004115 Filed on February 25, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VXRT
Vaxart, Inc. Stock $vxrt